News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,340 Results
Type
Article (41428)
Company Profile (268)
Press Release (681634)
Multimedia
Podcasts (80)
Webinars (17)
Section
Business (204885)
Career Advice (2031)
Deals (35568)
Drug Delivery (113)
Drug Development (82050)
Employer Resources (173)
FDA (16596)
Job Trends (14953)
News (347514)
Policy (32911)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2571)
Accelerated approval (31)
Adcomms (24)
Allergies (138)
Alliances (49658)
ALS (170)
Alzheimer's disease (1669)
Antibody-drug conjugate (ADC) (307)
Approvals (16862)
Artificial intelligence (506)
Autoimmune disease (150)
Automation (37)
Bankruptcy (361)
Best Places to Work (11648)
BIOSECURE Act (21)
Biosimilars (188)
Biotechnology (174)
Bladder cancer (159)
Brain cancer (56)
Breast cancer (635)
Cancer (4780)
Cardiovascular disease (409)
Career advice (1713)
Career pathing (35)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (734)
Cervical cancer (36)
Clinical research (70091)
Collaboration (1683)
Company closure (4)
Compensation (1148)
Complete response letters (54)
COVID-19 (2721)
CRISPR (89)
C-suite (818)
Cystic fibrosis (144)
Data (6178)
Decentralized trials (2)
Denatured (25)
Depression (133)
Diabetes (504)
Diagnostics (6682)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (247)
Drug pricing (186)
Drug shortages (29)
Duchenne muscular dystrophy (228)
Earnings (90118)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117402)
Executive appointments (962)
FDA (19691)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1453)
Gene editing (196)
Generative AI (43)
Gene therapy (589)
GLP-1 (1001)
Government (4672)
Grass and pollen (6)
Guidances (383)
Healthcare (18915)
HIV (56)
Huntington's disease (45)
IgA nephropathy (82)
Immunology and inflammation (250)
Immuno-oncology (55)
Indications (104)
Infectious disease (2987)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (111)
Intellectual property (242)
Interviews (319)
IPO (16662)
IRA (49)
Job creations (3642)
Job search strategy (1433)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (548)
Leadership (30)
Legal (7976)
Liver cancer (92)
Longevity (14)
Lung cancer (646)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (783)
MASH (163)
Medical device (13766)
Medtech (13818)
Mergers & acquisitions (19972)
Metabolic disorders (1281)
Multiple sclerosis (161)
NASH (21)
Neurodegenerative disease (316)
Neuropsychiatric disorders (89)
Neuroscience (2903)
Neurotech (1)
NextGen: Class of 2026 (6533)
Non-profit (4516)
Now hiring (65)
Obesity (608)
Opinion (258)
Ovarian cancer (165)
Pain (199)
Pancreatic cancer (222)
Parkinson's disease (283)
Partnered (33)
Patents (489)
Patient recruitment (478)
Peanut (55)
People (58873)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21801)
Phase 2 (30841)
Phase 3 (23028)
Pipeline (5150)
Policy (280)
Postmarket research (2598)
Preclinical (9215)
Press Release (64)
Prostate cancer (234)
Psychedelics (48)
Radiopharmaceuticals (278)
Rare diseases (833)
Real estate (5955)
Recruiting (70)
Regulatory (24595)
Reports (51)
Research institute (2389)
Resumes & cover letters (353)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (148)
Series A (237)
Series B (188)
Service/supplier (11)
Sickle cell disease (96)
Special edition (21)
Spinal muscular atrophy (161)
Sponsored (41)
Startups (3616)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (53)
Vaccines (989)
Venture capital (86)
Weight loss (395)
Women's health (87)
Worklife (18)
Date
Today (113)
Last 7 days (632)
Last 30 days (2106)
Last 365 days (29952)
2026 (2982)
2025 (30268)
2024 (35293)
2023 (40173)
2022 (51289)
2021 (55827)
2020 (54171)
2019 (46654)
2018 (35112)
2017 (32196)
2016 (31584)
2015 (37638)
2014 (31442)
2013 (26459)
2012 (28651)
2011 (29355)
2010 (27428)
Location
Africa (739)
Alabama (83)
Alaska (7)
Arizona (306)
Arkansas (13)
Asia (39561)
Australia (6466)
California (11187)
Canada (3258)
China (1104)
Colorado (473)
Connecticut (471)
Delaware (332)
Europe (84953)
Florida (1664)
Georgia (355)
Hawaii (3)
Idaho (61)
Illinois (859)
India (65)
Indiana (516)
Iowa (22)
Japan (420)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1372)
Massachusetts (8027)
Michigan (320)
Minnesota (622)
Mississippi (5)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2975)
New Mexico (28)
New York (2954)
North Carolina (1442)
North Dakota (8)
Northern California (5452)
Ohio (332)
Oklahoma (21)
Oregon (42)
Pennsylvania (2258)
Puerto Rico (23)
Rhode Island (47)
South America (1109)
South Carolina (66)
South Dakota (1)
Southern California (4356)
Tennessee (172)
Texas (1727)
United States (39684)
Utah (334)
Vermont (1)
Virginia (258)
Washington D.C. (81)
Washington State (914)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
723,340 Results for "anges mg inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vasomune Therapeutics Inc., and AnGes Inc., Expand the Scope of the Co-Development Agreement to Target Additional Indications
November 26, 2025
·
2 min read
Press Releases
EURneffy® 1 mg (adrenaline nasal spray) Recommended for Approval in the EU for Emergency Treatment of Type 1 Allergic Reactions, including Anaphylaxis in Children Weighing ≥15 kg to <30 kg
February 2, 2026
·
9 min read
Press Releases
ALK receives positive recommendation for EURneffy® 1 mg: A needle-free anaphylaxis treatment for children
January 30, 2026
·
2 min read
Press Releases
Public Advisory - Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug
February 9, 2026
·
3 min read
Press Releases
EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases
February 2, 2026
·
14 min read
Press Releases
Bone Solutions’ Mg OSTEOCRETE and Mg OSTEOINJECT Receive FDA Clearance for Pediatric Use in Patients Aged Six and Older
October 21, 2025
·
2 min read
Press Releases
Celltrion receives Health Canada approval for Eydenzelt®, a biosimilar referencing Eylea® (aflibercept 2mg)
November 28, 2025
·
3 min read
Press Releases
Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy® in a pill*) at ObesityWeek® 2025, including demonstrated reductions in cardiovascular risk factors
November 6, 2025
·
12 min read
Press Releases
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg
November 18, 2025
·
4 min read
Press Releases
Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg
November 27, 2025
·
6 min read
1 of 72,334
Next
